213 related articles for article (PubMed ID: 37784026)
21. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
22. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
23. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
[TBL] [Abstract][Full Text] [Related]
26. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
27. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract][Full Text] [Related]
28. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
[TBL] [Abstract][Full Text] [Related]
29.
Zhang YT; Xu LJ; Li L
Genet Test Mol Biomarkers; 2024 Jan; 28(1):10-21. PubMed ID: 38294357
[No Abstract] [Full Text] [Related]
30. Characterization of the bovine immunoglobulin lambda light chain constant IGLC genes.
Chen L; Li M; Li Q; Yang X; An X; Chen Y
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):284-94. PubMed ID: 18538861
[TBL] [Abstract][Full Text] [Related]
31. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
32. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
33. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
34. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
35. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
Front Genet; 2022; 13():908807. PubMed ID: 35832191
[No Abstract] [Full Text] [Related]
36. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
Song J; Xu F; An L; Yin Y; Liu J; Chai J; Yang Y; Li M; Jia Q; Wang Z
Pathol Res Pract; 2023 Jul; 247():154577. PubMed ID: 37257243
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Zhou J; Xu L; Zhou H; Wang J; Xing X
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510286
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of protease-activated receptor-2 (PAR
He S; Xu M; Xiong Z; Hu Y; Huo Q; Lu J; Lin Y; Yang L
J Cell Mol Med; 2021 Feb; 25(3):1415-1424. PubMed ID: 33369107
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Significance and Immunization of MSMO1 in Cervical Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Zheng G; Wang Z; Fan Y; Wang T; Zhang L; Wang M; Chen S; Jiang L
Front Genet; 2021; 12():705851. PubMed ID: 34759952
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
